Screener
Acadia Pharmaceuticals ACAD Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| (unaudited) | ||
| Assets | ||
| Cash and cash equivalents | $384,985 | $177,695 |
| Investment securities, available-for-sale | 571,489 | 641,991 |
| Accounts receivable, net | 150,642 | 121,457 |
| Interest and other receivables | 15,688 | 26,774 |
| Inventory | 32,372 | 34,670 |
| Prepaid expenses and other current assets | 69,369 | 59,526 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's short-term investments?
- Acadia Pharmaceuticals (ACAD) reported short-term investments of $571.49M in Q2 2026.
- How has Acadia Pharmaceuticals's short-term investments changed year-over-year?
- Acadia Pharmaceuticals's short-term investments increased by 12.4% year-over-year, from $508.36M to $571.49M.
- What is the long-term trend for Acadia Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's short-term investments has grown at a 16.0% compound annual growth rate (CAGR), from $305.93M to $641.99M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Acadia Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude